Estimated incidence of CRC in USA for 2015 is 144000 patients, data from IARC GLOBOCAN website. Worldwide incidence is 1477402. For liver cancer the numbers are 32727 (US) and 846582 (world)
You can search by country or region to get an estimate of numbers in areas likely to be able to access SIRT.
I wouldn't include liver mets that can have primary resection as likely SIRT candidates, but even if 20% of CRC develop unresectable liver only mets that's a huge increase in market before considering HCC.
Potential Market, page-2
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.008(4.92%) |
Mkt cap ! $67.91M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.0¢ | 15.5¢ | $399.7K | 2.5M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300000 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 141094 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |